Antinuclear Antibody Test Industry Value Chain Analysis and Market Trends 2032
The Antinuclear Antibody Test Market is gaining significant traction worldwide, driven by the rising prevalence of autoimmune disorders, increasing awareness about early disease diagnosis, and advancements in laboratory technologies. Valued at USD 1,690.27 million in 2024, the market is projected to expand at a robust CAGR of 13.60% from 2025 to 2032, reflecting the urgent demand for precise...